MarketersMEDIA / Newsroom / Infectious disease diagnostics Market Will Reach USD 12,882.1 Million by 2025: Meticulous Research®

Infectious disease diagnostics Market Will Reach USD 12,882.1 Million by 2025: Meticulous Research®

Share This Press Release

Infectious Disease Diagnostics Market by Product (Assays and Kits, Instruments, and Software & Services), Technology (Immunodiagnostics, NGS, PCR), Disease Type (Hepatitis, HIV, HPV, Tuberculosis), End User, and Geography - Global Forecast to 2025

— Infectious disease diagnostics market has shown strong growth pattern in recent year’s majorly due to increasing global prevalence of infectious diseases, growing awareness for early detection using specific diagnostic tests, growth in funding for research on infectious disease diagnostics, and shift in focus from centralized laboratories to decentralized point-of-care testing.

Meticulous Research® in its latest publication on infectious disease diagnostics market states that the global infectious disease diagnostics market will increase at a CAGR of 5.9% from 2019 to 2025 to reach USD 12,882.1 million by 2025. Wherein, geographically, North America commanded the largest share in this market followed by Europe. The major share of North America is mainly attributed to growing healthcare sector, increasing need to treat various infectious diseases, increasing healthcare expenditure, growing demand of point-of-care testing, increase in the research and development coupled with the development of novel advanced technologies for diagnosis, and large number of patient population.

Download free sample report and gain crucial industry insights @ https://www.meticulousresearch.com/download-sample-report/cp_id=4976

The report provides meticulous analysis of global infectious disease diagnostics market by segmenting it on the basis of product & services (consumables, instruments, and software and services), technology (immunodiagnostics, clinical microbiology, polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), DNA sequencing & next-generation sequencing (NGS), DNA microarray, and other technologies), disease type (Hepatitis, human immunodeficiency virus (HIV), hospital-acquired infections (HAIS), Human Papillomavirus (HPV), Tuberculosis (TB), Influenza, and other diseases), and end user (hospital/clinical laboratories, reference laboratories, academics/research institutes, and other end users).

Wherein, among technologies, immunodiagnostics segment commanded the largest share majorly due to increasing use of immunoassays in POC infectious disease testing; development of novel tests; rising trend of automation in immunoassay instruments.

The key players analyzed in the global infectious disease diagnostics market are Abbott Laboratories (U.S.), Danaher (U.S.), Bio-Rad Laboratories (U.S.), bioMérieux SA (France), F. Hoffmann-La Roche Ltd (Switzerland), BD (U.S.), DiaSorin S.p.A. (Italy), Meridian Bioscience, Inc. (U.S.), Quidel Corporation (U.S.), and Thermo Fisher Scientific Inc. (U.S.).

Browse in-depth Report on: https://www.meticulousresearch.com/product/infectious-disease-diagnostics-market-4976/

Key Topics Covered in This Report:
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency and Limitations
1.3.1. Currency
1.3.2. Limitations
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation

3. Executive Summary
3.1. Introduction
3.2. Market Dynamics
3.3. Product Segment Analysis
3.4. Technology Segment Analysis
3.5. Disease Type Segment Analysis
3.6. End User Segment Analysis
3.7. Regional Analysis
3.8. Competitive Analysis

4. Market insights
4.1. Market Overview
4.2. Drivers
4.2.1. Increasing Global Prevalence of Infectious Diseases
4.2.2. Growing Awareness for Early Detection Using Specific Diagnostic Tests
4.2.3. Growth in Funding for Research on Infectious Disease Diagnostics
4.2.4. Shift in Focus from Centralized Laboratories to Decentralized Point-Of-Care Testing
4.3. Restraints
4.3.1. Unfavorable and inadequate Reimbursement Scenario
4.4. Challenges
4.4.1. Lack of Awareness of Specific Symptoms and Diagnosis of Emerging infections
4.5. Opportunities
4.5.1. Advances in Genomics and Proteomics
4.5.2. Growing Awareness about Personalized Medicines
4.5.3. Growth Opportunities in Emerging Economies

5. Global Infectious Disease Diagnostics Market, by Product and Services
5.1. Introduction
5.2. Assays and Kits
5.3. Instruments
5.4. Software and Services

6. Global Infectious Disease Diagnostics Market, by Technology
6.1. Introduction
6.2. Immunodiagnostics
6.3. Clinical Microbiology
6.4. Polymerase Chain Reaction (PCR)
6.5. Isothermal Nucleic Acid Amplification Technology (INAAT)
6.6. DNA Sequencing & Next-Generation Sequencing (NGS)
6.7. DNA Microarray
6.8. Other Technologies

7. Global Infectious Disease Diagnostics Market, by Disease Type
7.1. Introduction
7.2. Hepatitis
7.3. HIV
7.4. Hospital-Acquired infections (HAIS)
7.5. Human Papillomavirus (HPV)
7.6. Tuberculosis (TB)
7.7. Influenza
7.8. Other Infectious Diseases

8. Global Infectious Disease Diagnostics Market, by End User
8.1. Introduction
8.2. Hospital/Clinical Laboratories
8.3. Reference Laboratories
8.4. Academics/Research institutes
8.5. Other End Users

9. Infectious Disease Diagnostics Market, by Region
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Rest of Europe (RoE)
9.4. Asia Pacific
9.4.1. China
9.4.2. Japan
9.4.3. Rest of Asia Pacific (ROAPAC)
9.5. Latin America
9.6. Middle East and Africa

10. Competitive Landscape
10.1. Overview
10.2. Inorganic Growth Strategies
10.2.1. Agreements, Collaborations, and Partnerships
10.2.2. Acquisitions
10.3. Organic Growth Strategies
10.3.1. Product and Service Launches
10.4. Market Positioning/Ranking
10.5. Performance of the Key Players
10.5.1. F. Hoffmann-La Roche Ltd
10.5.2. Abbott Laboratories
10.5.3. Danaher Corporation
10.5.4. BD

11. Company Profiles (Includes Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
11.1. Abbott Laboratories
11.2. Danaher
11.3. Bio-Rad Laboratories, Inc.
11.4. bioMérieux
11.5. F. Hoffmann-La Roche Ltd
11.6. BD (Becton, Dickinson and Company)
11.7. DiaSorin S.P.A.
11.8. Meridian Bioscience, Inc.
11.9. Quidel Corporation
11.10. Thermo Fisher Scientific Inc.

12. Appendix
12.1. Questionnaire
12.2. Available Customization

Download free sample report and gain crucial industry insights @ https://www.meticulousresearch.com/download-sample-report/cp_id=4976

Contact Info:
Name: Khushal
Email: Send Email
Organization: Meticulous Market Research Pvt. Ltd.
Address: Pune, India
Phone: +91-744-7780008
Website: https://www.meticulousresearch.com/product/infectious-disease-diagnostics-market-4976/

Source URL: https://marketersmedia.com/infectious-disease-diagnostics-market-will-reach-usd-128821-million-by-2025-meticulous-research/88889481

Source: MarketersMedia

Release ID: 88889481

Subscribe and Receive exclusive insider tips and tricks on Press Release.

Follow Us

Copyright © 2012 - 2019 MarketersMEDIA – Press Release Distribution Services – News Release Distribution Services. All Rights Reserved.

Powered by Semantics BigData Analytics (SBDA).